DermoDav
Member
''IRVINE, CALIF., July 20, 2004 -- Allergan Inc. announced that the FDA has approved Botox (botulinum toxin type A) for the treatment of severe primary axillary hyperhidrosis (severe underarm sweating) that is inadequately managed with topical agents.''
8 years later in Australia Medicare has subsidised BOTOX for axillary HH. 8 Years!
Medicare pays for psoriasis treatments such as Biologics (19 thousand dollars per patient per year) and phototherapy treatments (no capped sessions) but despite numerous emails to insurance companies and the government public health agencies (Medicare), treatments such as Iontophoresis are not covered.
I think its a lack of government insight in regards to the impact of HH on patient's relationships, work, social and self-esteem.
This question is rhetorical...however how can HH patients can a fair deal? In my view as a dermatologist, the impact of HH is just as significant as psoriasis patients, but HH patient get a raw deal as this condition is not visual (in comparison to a red scaly rash like psoriasis).
8 years later in Australia Medicare has subsidised BOTOX for axillary HH. 8 Years!
Medicare pays for psoriasis treatments such as Biologics (19 thousand dollars per patient per year) and phototherapy treatments (no capped sessions) but despite numerous emails to insurance companies and the government public health agencies (Medicare), treatments such as Iontophoresis are not covered.
I think its a lack of government insight in regards to the impact of HH on patient's relationships, work, social and self-esteem.
This question is rhetorical...however how can HH patients can a fair deal? In my view as a dermatologist, the impact of HH is just as significant as psoriasis patients, but HH patient get a raw deal as this condition is not visual (in comparison to a red scaly rash like psoriasis).